Comparative study of the safety and efficacy of levofloxacin and ciprofloxacin in the treatment of community-acquired, bacterial urinary tract infection among patients with chronic kidney disease
Phase 3
Completed
- Conditions
- Urinary tract infection, Chronic kidney diseaseKidney Disease
- Registration Number
- PACTR202401622249032
- Lead Sponsor
- Dhikrullah Adebayo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
1.Age 18years and above.
2.Known CKD patients
3.Symptoms compatible with a diagnosis of UTI plus positive dipstick test for pyuria
4.Informed consent to participate in the study.
Exclusion Criteria
1.Patients with any rapidly progressive or terminal disease
2.Individuals with prior renal transplantation.
3.Co-existence of other infections in addition to urinary tract infection
4.Exposure to any antimicrobial prior to presentation
5.Known previous reaction to quinolones.
6.Hospital acquired UTI
7.Catheter associated UTI
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method